In an article published by Law360, health care partner Tom Bulleit (Washington, D.C.) discussed President Trump’s latest drug pricing executive order that seeks to sharply cut drug prices by capping prices of Medicare Part B and Part D drugs.
Tom explained that the executive order, which came right before the U.S. presidential election, would be met with legal challenges that would set up further obstacles to implementation.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.